Insights

Innovative Immunotherapy Platform Dragonfly Therapeutics utilizes a proprietary multispecific antibody technology to develop immune-based therapies, presenting a strong opportunity for collaborations with pharmaceutical companies seeking advanced immunotherapy solutions.

Strategic Collaborations The company has established partnerships with major industry players like Merck, AbbVie, Gilead, and Bristol Myers Squibb, indicating a receptive approach to joint development and licensing deals that can be expanded further.

Pipeline Expansion With a deep pipeline of wholly owned preclinical and clinical assets, Dragonfly offers multiple potential collaboration points for investors or partners interested in early-stage and breakthrough biologics.

Leadership Growth Recent executive appointments, including new CEO and President of R&D, signal focused growth and strategic direction, making the company a compelling partner for co-developers and resource sharing initiatives.

Market Focus on Immune-Mediated Diseases Dragonfly’s emphasis on immune-mediated and inflammatory diseases aligns well with current market trends, providing sales opportunities in biotech instruments, research collaborations, and targeted therapeutics development.

Dragonfly Therapeutics, Inc. Tech Stack

Dragonfly Therapeutics, Inc. uses 8 technology products and services including Evisort, SAP, Webpack, and more. Explore Dragonfly Therapeutics, Inc.'s tech stack below.

  • Evisort
    Customer Relationship Management
  • SAP
    Customer Relationship Management
  • Webpack
    Development
  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Oracle
    Enterprise
  • DocuSign
    Miscellaneous
  • New Relic
    Real User Monitoring

Media & News

Dragonfly Therapeutics, Inc.'s Email Address Formats

Dragonfly Therapeutics, Inc. uses at least 1 format(s):
Dragonfly Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@dragonflytx.comJohn.Doe@dragonflytx.com
80%
First@dragonflytx.comJohn@dragonflytx.com
18%
FirstMiddle.Last@dragonflytx.comJohnMichael.Doe@dragonflytx.com
1%
Fir.Last@dragonflytx.comJoh.Doe@dragonflytx.com
1%

Frequently Asked Questions

Where is Dragonfly Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s main headquarters is located at Waltham, Massachusetts 02451 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Dragonfly Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Dragonfly Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dragonfly Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s official website is dragonflytx.com and has social profiles on LinkedIn.

What is Dragonfly Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dragonfly Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Dragonfly Therapeutics, Inc. has approximately 52 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: B. H.Chief Operating Officer: J. U.Chief Scientific Officer And Head Of Research And Development: A. C.. Explore Dragonfly Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Dragonfly Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Dragonfly Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s tech stack includes EvisortSAPWebpackNetSuiteMicrosoft ExcelOracleDocuSignNew Relic.

What is Dragonfly Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc.'s email format typically follows the pattern of First.Last@dragonflytx.com. Find more Dragonfly Therapeutics, Inc. email formats with LeadIQ.

When was Dragonfly Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Dragonfly Therapeutics, Inc. was founded in 2016.

Dragonfly Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.

Section iconCompany Overview

Headquarters
Waltham, Massachusetts 02451 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Dragonfly Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Dragonfly Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.